ConvenienceThe convenience patients deserve
How to Use
Show your patients how to self-administer FASENRA Pen, a convenient administration option.
Patients/Caregivers may administer with FASENRA Pen after proper training in subcutaneous injection technique and after the healthcare professional determines it is appropriate.
More than 96% of patients successfully self-administered with FASENRA Pen.*1
*28-week, open-label study designed to assess the functionality and reliability of single-use autoinjectors for at-home administration. After training and successful administration under study-site supervision, of the 116 at-home administrations, 97.4% (n=113) and 96.6% (n=112) were successfully administered by patients or caregivers at Weeks 12 and 16, respectively.1
YOU ARE ABOUT TO LEAVE FASENRA.COM
Please note: AstraZeneca does not control, review, or endorse third-party content and is not responsible for the content you are about to access. We provide links to external Web sites as a convenience and for educational purpose only.
Would you like to continue to an external link?